Viva Biotech Holdings
Research Viva Biotech Holdings (VB0) on Bullrun: market cap EUR 255.94M, P/E 12.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVB0
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 255.94M
- P/E12.3
- Financial periodFY2024
- RevenueEUR 1.99B
- Revenue growth-7.8%
- Net incomeEUR 167.29M
- Free cash flowEUR 182.32M
- Gross margin34.6%
Valuation Snapshot
latest market cap is EUR 255.94M; P/E is 12.3.
About Viva Biotech Holdings
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacology and DMPK;
Frequently asked questions
What is Viva Biotech Holdings's market cap?
Viva Biotech Holdings's market capitalization is EUR 255.94M.
What is Viva Biotech Holdings's P/E ratio?
Viva Biotech Holdings's price-to-earnings (P/E) ratio is 12.3.
What does Viva Biotech Holdings do?
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.